Propofol
- Generic Name
- Propofol
- Brand Names
- Diprivan
- Drug Type
- Small Molecule
- Chemical Formula
- C12H18O
- CAS Number
- 2078-54-8
- Unique Ingredient Identifier
- YI7VU623SF
- Background
Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. ...
- Indication
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
- Associated Conditions
- -
- Associated Therapies
- Induction of anesthesia therapy, Maintenance of anesthesia therapy, Monitored anesthesia care sedation, Sedative therapy
Differences in Speed of Recovery From Anesthesia for Intraoral Surgery
- First Posted Date
- 2024-02-23
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Clinical Hospital Centre Zagreb
- Target Recruit Count
- 42
- Registration Number
- NCT06275087
- Locations
- 🇭🇷
University Hospital Centre Zagreb, Zagreb, Croatia
Ciprofol Titrated Induction in Reducing Post-induction Hypotension in Geriatric Patients
- Conditions
- Interventions
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2024-07-15
- Target Recruit Count
- 160
- Registration Number
- NCT06258967
- Locations
- 🇨🇳
the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Efficacy and Safety of Fospropofol for Same-day Bidirectional Endoscopy in Elderly Patients
- Conditions
- Interventions
- First Posted Date
- 2024-02-09
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Shanghai 6th People's Hospital
- Target Recruit Count
- 256
- Registration Number
- NCT06251999
Ketamine Versus Propofol as ICU Sedation
- Conditions
- Interventions
- First Posted Date
- 2024-02-06
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Menoufia University
- Target Recruit Count
- 100
- Registration Number
- NCT06243822
- Locations
- 🇪🇬
Menoufia University, Shibīn Al Kawm, Menoufia, Egypt
Efficacy of Low Dose Propofol Given at the End of Sevoflurane Anesthesia for Prevention of Emergence Agitation in Pediatric Patient Undergoing MRI Scan
- Conditions
- Interventions
- First Posted Date
- 2024-01-23
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Khon Kaen University
- Target Recruit Count
- 134
- Registration Number
- NCT06218680
- Locations
- 🇹🇭
Khon kaen University, Khon Kaen, Muang, Thailand
Recovery of TIVA vs Inhalation in Pediatric Anesthesia
- Conditions
- Interventions
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 120
- Registration Number
- NCT06215833
A Low Dose Dexmedetomidine in Sedation Colonoscopy
- Conditions
- Interventions
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 104
- Registration Number
- NCT06208956
The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Randomized Controlled Trial
- Conditions
- Interventions
- First Posted Date
- 2024-01-12
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Siriraj Hospital
- Target Recruit Count
- 214
- Registration Number
- NCT06203405
- Locations
- 🇹🇭
Siriraj Hospital, Bangkok, Thailand
Propofol for Prophylaxis of Morphine Induced Pruritis in Caesarean Section
- First Posted Date
- 2024-01-03
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 200
- Registration Number
- NCT06188546
The Effects of Remimazolam on the Incidence of Severe Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients
- Conditions
- Interventions
- First Posted Date
- 2024-01-03
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT06187896
- Locations
- 🇨🇳
Diansan Su, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.